First Manhattan
IDYA icon

First Manhattan’s IDEAYA Biosciences IDYA Stock Holding History

First Manhattan’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-593,065
Closed -$16M – 1498
2023
Q3 		$16M Hold
593,065
– – 0.06% 115
2023
Q2 		$13.9M Buy
593,065
+427,865
+259% +$8.8M 0.05% 114
2023
Q1 		$2.27M Hold
165,200
– – 0.01% 301
2022
Q4 		$3M Hold
165,200
– – 0.01% 283
2022
Q3 		$2.46M Buy
+165,200
New +$2.15M 0.01% 294
2021
Q1 		– Sell
-296
Closed -$4K – 1509
2020
Q4 		$4K Buy
+296
New +$4.01K ﹤0.01% 1225

Other funds holding IDYA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

First Manhattan's IDYA Position: Q4 2023 in Review

First Manhattan sold out of IDEAYA Biosciences (IDYA) in Q4 2023, closing a stake of 593,065 shares — an estimated $16M sold.

First Manhattan first reported a position in IDYA in Q4 2020 and held it in 6 quarters. The position peaked at $16M in Q3 2023. 157 funds tracked by Wall St. Rank hold IDYA as of Q4 2023.

  • First Manhattan reported no remaining IDEAYA Biosciences position as of Q4 2023 after selling out during the quarter.
  • First Manhattan sold 593,065 IDEAYA Biosciences shares in Q4 2023, an estimated $16M.
  • First Manhattan first reported a position in IDEAYA Biosciences in Q4 2020 and held it in 6 quarters.
  • First Manhattan's IDEAYA Biosciences position peaked at $16M in Q3 2023.
  • 157 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q4 2023.

Based on First Manhattan's 13F filing for Q4 2023, filed 13 Feb 2024.